Boston University School of Medicine’s (BUSM) researchers have found that sociodemographic characteristics are related to a patients’ willingness to participate in cancer screenings. They found this was more important than both attitudinal barriers and medical facilitors. This study appears in the March issue of the Journal of the National Medical Association… Read Full Article

CytoCore Inc… Read Full Article

Women older than age 40 are not likely to receive a substantial benefit from vaccination against the human papillomavirus, according to a study published in the Journal of the National Cancer Institute, the New York Times reports… Read Full Article

Results of the U.S. Food and Drug Administration (FDA) pivotal clinical trial for the Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) LightTouch™ Non-invasive Cervical Cancer Detection System are scheduled to be presented by five leading doctors at the American Society for Colposcopy and Cervical Pathology biennial meeting, March 24 – 27, 2010, in Las Vegas… Read Full Article

A survey released Monday of 150 breast cancer health educators and providers from 48 states and Washington, D.C., found that roughly one-fourth say their states have limited mammography services and other early detection programs for women younger than age 50 since the U.S… Read Full Article

Several news outlets examine the latest reports out of this week’s Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. Researchers from the Maryland-based VIRxSYS Corporation on Thursday presented data on the outcomes of the company’s HIV vaccine, VRX1023, from a recent trial carried out in monkeys, Reuters reports… Read Full Article

After testing dozens of samples from marine mammals, University of Florida aquatic animal health experts say dolphins may be the ideal model for the study of cervical cancer in people… Read Full Article

Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S… Read Full Article

Merck’s human papillomavirus vaccine, Gardasil, effectively prevented precancerous cervical lesions and genital warts in women ages 24 through 45, and it prevented anal cancer and precancerous anal lesions in young men who have sex with men, according to two studies released by the company on Wednesday, the AP/Philadelphia Inquirer reports… Read Full Article

QuantRx® Biomedical Corporation (OTCBB:QTXB), an emerging leader in the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide point-of-care healthcare industry, announced that its proprietary PadKit has been selected as the sample collection system by the UCLA School of Nursing for a comparative cyto… Read Full Article